Of these components, MBL2 and FCN3 are some of the mannose-binding lectin pathways’ complement initiators that bind to antigens on the cell membrane of cancer cells or cells, initiating the activation of the complement cascade [31]. The gene discussed is MBL2; the disease is cancer.